An open label, cross-over, randomised study to evaluate the bioequivalence and the effect of food on pharmacokinetics of vildagliptin/metformin fixed dose combination compared to free combinations in healthy Japanese subjects

Trial Profile

An open label, cross-over, randomised study to evaluate the bioequivalence and the effect of food on pharmacokinetics of vildagliptin/metformin fixed dose combination compared to free combinations in healthy Japanese subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs Vildagliptin/metformin (Primary) ; Metformin; Vildagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 11 Mar 2016 New trial record
    • 02 Mar 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top